Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Preeclampsia is a leading cause of maternal and neonatal death worldwide, yet effective strategies are lacking for prevention and treatment. A new paper published in the New England Journal of Medicine, explores the Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

Pre-eclampsia affects some pregnant women, usually during the second half of pregnancy (from around 20 weeks) or soon after their baby is delivered.
Pre-eclampsia affects some pregnant women, usually during the second half of pregnancy (from around 20 weeks) or soon after their baby is delivered.

Upcoming OxTalks

Our Research Groups